Answers are grounded in this paper and cite their sources.
In Brief Objective To assess the safety of a new platelet count threshold for the definition of maternal thrombocytopenia late in pregnancy. Methods A platelet count was performed in 6770 pregnant women late in pregnancy and in 6103 of their newborns as well as in a control group of 287 age-matched nonpregnant healthy women. Results The prevalence of maternal thrombocytopenia (platelet count less than 150 × 109/L) was 11.6%. The mean platelet counts (248 compared with 213 × 109/L) and 2.5th percentile (164 compared with 116 × 109/L) were significantly higher in healthy nonpregnant women than in pregnant women. Among thrombocytopenic pregnant women, 621 (79%) had platelet counts between 116 and 149 × 109/L; none (0%; 95% confidence interval 0, 0.6) had complications related to thrombocytopenia, and none of their newborns had severe thrombocytopenia (platelet count less than 20 × 109/L). Conclusion In healthy pregnant women, a platelet count over 115 × 109/L late in pregnancy does not require further investigation during pregnancy and may be considered a safe threshold. In healthy pregnant women, a platelet count greater than 115 × 109/L late in pregnancy does not require further investigation during pregnancy.
No takes yet. Share an insight, caveat, or question.
Boehlen et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: